April 21, 2025
DC Quick Takes: Reconciliation/Tax Cuts, Medicaid, Defense Spending, Immigration, SNAP Cuts, President’s Budget and Trade
Congress returns from recess next week where work is expected to pick up on the reconciliation/tax bill, with various committees beginning to mark up the legislation over the next two weeks. During the next month…
April 21, 2025
Diagnostics: Supreme Court Quick Takes
Following oral arguments this morning, we continue to believe that the Supreme Court will preserve HHS authority to enforce mandatory cost-free coverage of U.S. Preventive Services Task Force (USPSTF) recommendations, preserving the positive status quo…
April 21, 2025
Diagnostics & Supreme Court Expectations
With the Supreme Court (SCOTUS) to hear oral arguments this morning 10-11 am ET [live stream] on the legality of mandatory cost-free coverage of U.S. Preventive Services Task Force (USPSTF) recommendations, we reiterate our long-held…
April 17, 2025
Trade and Tariff Conference Call Takeaways
We hosted a conference call yesterday with a trade expert, who has advised various politicians in Washington, and give our takeaways and update views on trade. You can click here for a link to the…
April 17, 2025
Rx Executive Order: Style of Substance
Despite investor fears of a return of Most Favored Nation (MFN) pricing efforts under Trump, explicit endorsement of such a policy is notably absent from this week’s Executive Order (EO) on drug pricing, despite multiple…
April 17, 2025
Life Science Tools: NIH Headwinds & Congressional Guardrails
With press reports indicating that the White House will seek NIH funding cuts of more than 40% in its upcoming FY26 budget release, the overhang on life science tools (LST) names [BRKR, ILMN, AVTR, A,…
April 16, 2025
Trump Biopharma EO: Laying the Groundwork for Additional Hospital Reconciliation Targets [municipal-backed, HCA, THC, CYH, ARDT, UHS]
President Trump’s executive order (EO) on biopharma yesterday suggests the hospital sector is a larger target than administration officials have let on to date and seems to proffer more substance about additional ways to garner…
April 15, 2025
Rx Tariff Timing & Supply Chain Implications
With the Trump administration announcing its long-anticipated Section 232 pharmaceutical investigation yesterday, laying the foundation for eventual tariffs on the space, we expect this to move much quicker than the typical 232 case (e.g., 2-3…
April 14, 2025
Medtech & Medicare Inpatient Implications
Friday’s draft FY26 rate rule for Medicare inpatient hospital services brings incremental benefits for the likes of BSX, DXCM, ABT, and MMSI through proposed endorsement of new technology add-on payments (NTAP) that we expect to…
April 13, 2025
Vanilla Medicare Inpatient Provider Proposals [HCA, THC, ARDT, EHC, SEM, CHE, ADUS, ENSG, PACS, UHS, ACHC]
Medicare’s proposed FY26 payment regulations for inpatient hospitals [HCA, THC, CYH, ARDT, UHS, MPW, municipal bond-backed facilities], inpatient rehab facilities (IRFs) [EHC, SEM], hospices [CHE, ADUS, Gentiva], long-term care hospitals (LTCHs) [SEM, Kindred], skilled nursing…